Replica injectable weight-loss drugs will be banned to protect Australians from severe side effects that have led to hospitalisation.
Medications that mimic appetite suppressant diabetes drugs Ozempic and Mounjaro will be prohibited from October.
About 20,000 Australians inject the imitation medication, leading to a rise in hospitalisations from adverse effects of the unregulated products.